WHO ICTRP trial
The effect of intrathecal methylprednisolone on features of central…
ISRCTN01838427 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN01838427 |
|---|---|
| Public title | The effect of intrathecal methylprednisolone on features of central sensitisation in patients with chronic complex regional pain syndrome (CRPS) type one |
| Scientific title | The effect of intrathecal methylprednisolone on features of central sensitisation in patients with chronic complex regional pain syndrome (CRPS) type one |
| Primary sponsor | Leiden University Medical Centre (LUMC) (The Netherlands) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | Netherlands |
| Conditions | Chronic complex regional pain syndrome type 1 (CRPS I) Signs and Symptoms Complex regional pain syndrome |
| Interventions | In all patients a lumbar puncture will be performed. After a lumbar puncture 5 ml of fluid is removed for cytologic and biochemical tests. An additional 5 ml of fluid will be removed for the measurement of the level of cytokines. Then 60 mg… |
| Registration date | Jan 23, 2006 |
| Target size | 80 |
| Secondary IDs | BSIK03016; NTR61 |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: